Literature DB >> 32269719

MicroRNA-143 suppresses the proliferation and metastasis of human gastric cancer cells via modulation of STAT3 expression.

Yuanyu Wu1, Xiaoyu Wan2, Xin Zhao3, Zheyu Song1, Zhonghang Xu1, Youmao Tao1, Caixia Sun1.   

Abstract

Accumulating evidences suggest that miRNAs may prove essential therapeutic targets for the treatment of cancer. Herein, the role and therapeutic implications of miRNA-143 was investigated in gastric cancer. The results revealed miRNA-143 to be aberrantly downregulated in gastric cancer cell lines. Ectopic expression of miRNA-143 resulted in a significant (P<0.05) inhibition of AGS gastric cancer cell proliferation suggestive of the tumor suppressive role of miRNA-143. The inhibition of AGS cell proliferation was mainly via activation of apoptotic cell death as evident from the AO/EB and annexin V/PI staining. Additionally, miR-143 overexpression also caused a significant (P<0.05) decline in the migration and invasion of AGS cells. TargetScan analysis and the dual luciferase assay revealed STAT3 to be the potential target of miRNA-143 in AGS cells. Analysis of STAT3 expression in gastric cancer cell lines showed upto 3.5 fold upregulation of STAT3. However, miRNA-143 overexpression resulted in considerable downregulation of STAT3 expression. Silencing of STAT3 also resulted in the inhibition of cell proliferation, migration and invasion of the AGS cells. Moreover, overexpression of STAT3 could nullify the tumor suppressive effects of miRNA-143 in AGS cells. Taken together, miRNA-143 has a tumor suppressive role in gastric cancer and may prove essential in gastric cancer treatment. AJTR
Copyright © 2020.

Entities:  

Keywords:  Gastric cancer; apoptosis; miRNA-143; migration; tumor suppressor

Year:  2020        PMID: 32269719      PMCID: PMC7137056     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  23 in total

Review 1.  miRNAs, cancer, and stem cell division.

Authors:  Carlo M Croce; George A Calin
Journal:  Cell       Date:  2005-07-15       Impact factor: 41.582

2.  A powerful and flexible linear mixed model framework for the analysis of relative quantification RT-PCR data.

Authors:  Juan Pedro Steibel; Rosangela Poletto; Paul M Coussens; Guilherme J M Rosa
Journal:  Genomics       Date:  2009-05-05       Impact factor: 5.736

Review 3.  Clinical epidemiology of gastric cancer.

Authors:  Tiing Leong Ang; Kwong Ming Fock
Journal:  Singapore Med J       Date:  2014-12       Impact factor: 1.858

4.  Interleukin-1 polymorphisms associated with increased risk of gastric cancer.

Authors:  E M El-Omar; M Carrington; W H Chow; K E McColl; J H Bream; H A Young; J Herrera; J Lissowska; C C Yuan; N Rothman; G Lanyon; M Martin; J F Fraumeni; C S Rabkin
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

Review 5.  Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention.

Authors:  Parisa Karimi; Farhad Islami; Sharmila Anandasabapathy; Neal D Freedman; Farin Kamangar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.254

Review 6.  Origins and Mechanisms of miRNAs and siRNAs.

Authors:  Richard W Carthew; Erik J Sontheimer
Journal:  Cell       Date:  2009-02-20       Impact factor: 41.582

Review 7.  Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  E Riboli
Journal:  Ann Oncol       Date:  1992-12       Impact factor: 32.976

Review 8.  Review article: the epidemiology and prevention of gastric cancer.

Authors:  K M Fock
Journal:  Aliment Pharmacol Ther       Date:  2014-06-10       Impact factor: 8.171

9.  MicroRNA-143 as a tumor suppressor for bladder cancer.

Authors:  Tianxin Lin; Wen Dong; Jian Huang; Qiuhui Pan; Xinlan Fan; Caixia Zhang; Li Huang
Journal:  J Urol       Date:  2009-01-20       Impact factor: 7.450

10.  Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells.

Authors:  Siqin Bao; Fuchou Tang; Xihe Li; Katsuhiko Hayashi; Astrid Gillich; Kaiqin Lao; M Azim Surani
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

View more
  8 in total

Review 1.  Signaling pathways and therapeutic interventions in gastric cancer.

Authors:  Zi-Ning Lei; Qiu-Xu Teng; Qin Tian; Wei Chen; Yuhao Xie; Kaiming Wu; Qianlin Zeng; Leli Zeng; Yihang Pan; Zhe-Sheng Chen; Yulong He
Journal:  Signal Transduct Target Ther       Date:  2022-10-08

2.  MiR-205-5p Functions as a Tumor Suppressor in Gastric Cancer Cells through Downregulating FAM84B.

Authors:  Xi Chen; Lei Zhang; JingBo Geng; Zhong Chen; XiaoPeng Cui
Journal:  J Oncol       Date:  2022-05-27       Impact factor: 4.501

3.  Correlation analysis of microribonucleic acid-155 and microribonucleic acid-29 with type 2 diabetes mellitus, and the prediction and verification of target genes.

Authors:  Jiaojiao Zhu; Cuizhe Wang; Xueting Zhang; Tongtong Qiu; Yinghua Ma; Xue Li; Huai Pang; Jianyu Xiong; Xin Yang; Chongge Pan; Jianxin Xie; Jun Zhang
Journal:  J Diabetes Investig       Date:  2020-08-03       Impact factor: 4.232

4.  CircMMP11 overexpression predicts the poor survival of non-small cell lung cancer and downregulates miR-143 through methylation to suppress cell proliferation.

Authors:  Juan Chen; Jiang Gong
Journal:  J Cardiothorac Surg       Date:  2021-11-08       Impact factor: 1.637

5.  Association Between Polymorphisms in Gastric Cancer Related Genes and Risk of Gastric Cancer: A Case-Control Study.

Authors:  Yan Pu; Xu Wen; Zhangjun Jia; Yu Xie; Changxing Luan; Youjia Yu; Feng Chen; Peng Chen; Ding Li; Yan Sun; Jian Zhao; Haiqin Lv
Journal:  Front Mol Biosci       Date:  2021-05-17

6.  MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells.

Authors:  Yiqun Du; Jian Zhang; Yanchun Meng; Mingzhu Huang; Wangjun Yan; Zhiqiang Wu
Journal:  AMB Express       Date:  2020-07-31       Impact factor: 3.298

Review 7.  STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Sima Orouei; Vahideh Zarrin; Ebrahim Rahmani Moghadam; Amirhossein Zabolian; Shima Mohammadi; Kiavash Hushmandi; Yashar Gharehaghajlou; Pooyan Makvandi; Masoud Najafi; Reza Mohammadinejad
Journal:  Biology (Basel)       Date:  2020-06-12

8.  miR-149 Suppresses the Proliferation and Metastasis of Human Gastric Cancer Cells by Targeting FOXC1.

Authors:  Dan Li; Yunqing Zhang; Yulong Li; Xiaofei Wang; Fenghui Wang; Juan Du; Huahua Zhang; Haiyan Shi; Yanfeng Wang; Yi Gao; Yun Feng; Jing Yan; Yajuan Xue; Yang Yang; Jing Zhang
Journal:  Biomed Res Int       Date:  2021-12-17       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.